Project Oncology®
Showcasing major breakthroughs in cancer care from worldwide clinical trials, Project Oncology® educates and assists the healthcare professionals who dedicate their lives to helping patients fight cancer.
Here you’ll find leading oncologists discuss and share essential cancer care strategies for all different types of cancer. And as worldwide clinical trials continue to explore new screening tests and discover novel treatment options, you can rest assured that you’ll always catch the latest in cancer research with Project Oncology®.
76-90 of 360
Chronic Graft-Versus-Host Disease Care: Evolving Therapeutic Strategies
Project Oncology®Chronic Graft-Versus-Host Disease Care: Evolving Therapeutic Strategies
Reevaluating Race in Spirometry: Advancing Equity in Pulmonary Risk Assessment
Project Oncology®Reevaluating Race in Spirometry: Advancing Equity in Pulmonary Risk Assessment
Modernizing Pulmonary Assessment: Reassessing Race-Neutral Interpretation in Practice
Project Oncology®Modernizing Pulmonary Assessment: Reassessing Race-Neutral Interpretation in Practice
Evaluating Axatilimab in Chronic GVHD: How Prior Therapies Impact Outcomes
Project Oncology®Evaluating Axatilimab in Chronic GVHD: How Prior Therapies Impact Outcomes
Advancing Biomarker Testing Strategies in Upper GI Cancers: From PD-L1 to FGFR2b
Project Oncology®Advancing Biomarker Testing Strategies in Upper GI Cancers: From PD-L1 to FGFR2b
Evaluating Patient and Clinician-Reported Responses to Axatilimab in cGVHD
Project Oncology®Evaluating Patient and Clinician-Reported Responses to Axatilimab in cGVHD
- advertisement
Advancing Precision Medicine in NSCLC: Real-World Impact of the PREDICT Initiative
Project Oncology®Advancing Precision Medicine in NSCLC: Real-World Impact of the PREDICT Initiative
Impacts of Multidisciplinary Tumor Boards and Surgery Integration on NSCLC Survival
Project Oncology®Impacts of Multidisciplinary Tumor Boards and Surgery Integration on NSCLC Survival
AAT C-Terminal Peptides Show Independent Prognostic Value in Early-Stage NSCLC
Project Oncology®AAT C-Terminal Peptides Show Independent Prognostic Value in Early-Stage NSCLC
Early Liquid Biopsy in Advanced Lung Cancer: Real-World Data Suggest Targeted Gains
Project Oncology®Early Liquid Biopsy in Advanced Lung Cancer: Real-World Data Suggest Targeted Gains
Managing Chronic Graft-Versus-Host Disease with CSF1R Inhibition
Project Oncology®Managing Chronic Graft-Versus-Host Disease with CSF1R Inhibition
Advances in Disease-Modifying and Curative Therapies for Sickle Cell Disease
Project Oncology®Advances in Disease-Modifying and Curative Therapies for Sickle Cell Disease
- advertisement
CRISPR in Sickle Cell: Transforming Care Through Gene Editing
Project Oncology®CRISPR in Sickle Cell: Transforming Care Through Gene Editing
Evaluating Gene Therapy for Sickle Cell Disease: Advantages and Barriers
Project Oncology®Evaluating Gene Therapy for Sickle Cell Disease: Advantages and Barriers
Curative Strategies for Sickle Cell Disease: The Future of Gene Editing
Project Oncology®Curative Strategies for Sickle Cell Disease: The Future of Gene Editing
